Adolescents' Experiences Using the Contraceptive Patch versus Pills

Journal of Pediatric and Adolescent Gynecology

Volumn 24, Issue 4, 2011, Pages 197-203

  Sucato, Gina S ^a   Land, Stephanie R ^b   Murray, Pamela J ^a   Cecchini, Reena ^b   Gold, Melanie A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Adolescents; Adverse effects; Contraception; Medication adherence

Indexed keywords

ETHINYLESTRADIOL; ETHINYLESTRADIOL PLUS LEVONORGESTREL; ETHINYLESTRADIOL PLUS NORGESTIMATE;

ACNE; ADOLESCENT; ADULT; ARTICLE; BREAST TENDERNESS; CLINICAL TRIAL; COMPARATIVE STUDY; CRYING; DEPRESSION; DISEASE SEVERITY; DIZZINESS; DRUG INDUCED HEADACHE; FATIGUE; FEMALE; FOLLOW UP; HAIR LOSS; HUMAN; IRRITABILITY; LIBIDO; LIBIDO DISORDER; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MOOD CHANGE; MUSCLE CRAMP; NAUSEA; ORAL CONTRACEPTION; OUTPATIENT DEPARTMENT; PATIENT SATISFACTION; PILL; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SIDE EFFECT; TRANSDERMAL PATCH; VOMITING; WEIGHT GAIN; WEIGHT REDUCTION;

ADOLESCENT; AFFECT; CONTRACEPTIVE AGENTS, FEMALE; CONTRACEPTIVES, ORAL; ESTROGENS; ETHINYL ESTRADIOL; FEMALE; HUMANS; LEVONORGESTREL; LONGITUDINAL STUDIES; MENSTRUATION; NORGESTREL; PATIENT SATISFACTION; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; TRANSDERMAL PATCH; YOUNG ADULT;

EID: 79959989470     PISSN: 10833188     EISSN: 18734332     Source Type: Journal    
DOI: 10.1016/j.jpag.2011.02.001     Document Type: Article

References (45)

1. Martin J.A., Hamilton B.E., Sutton P.D., et al. Births: Final data for 2006, (Vol. 57, no 7.) 2009, National Center for Health Statistics, Hyattsville, MD.
2. Henshaw S.K. Unintended pregnancy in the United States. Fam Plann Perspect 1998, 30:24.
3. Jones R.K., Darroch J.E., Henshaw S.K. Contraceptive use among U.S. women having abortions in 2000-2001. Perspect Sex Reprod Health 2002, 34:294.
4. Urdl W., Apter D., Alperstein A., et al. Contraceptive efficacy, compliance and beyond: factors related to satisfaction with once-weekly transdermal compared with oral contraception. Eur J Obstet Gynecol Reprod Biol 2005, 121:202.
5. Weisberg F., Bouchard C., Moreau M., et al. Preference for and satisfaction of Canadian women with the transdermal contraceptive patch versus previous contraceptive method: an open-label, multicentre study. J Obstet Gynaecol Can 2005, 27:350.
6. Archer D.F., Bigrigg A., Smallwood G.H., et al. Assessment of compliance with a weekly contraceptive patch (Ortho Evra/Evra) among North American women. Fertil Steril 2002, 77(Suppl 2):S27.
7. Archer D.F., Cullins V., Creasy G.W., et al. The impact of improved compliance with a weekly contraceptive transdermal system (Ortho Evra) on contraceptive efficacy. Contraception 2004, 69:189.
8. Bodner K., Bodner-Adler B., Grünberger W. Evaluation of the contraceptive efficacy, compliance, and satisfaction with the transdermal contraceptive patch system Evra: a comparison between adolescent and adult users. Arch Gynecol Obstet 2011, 283:525.
9. Harel Z., Riggs S., Vaz R., et al. Adolescents' experience with the combined estrogen and progestin transdermal contraceptive method Ortho Evra. J Pediatr Adolesc Gynecol 2005, 18:85.
10. Rubinstein M.L., Halpern-Felsher B.L., Irwin C.E. An evaluation of the use of the transdermal contraceptive patch in adolescents. J Adolesc Health 2004, 34:395.
11. Bakhru A., Stanwood N. Performance of contraceptive patch compared with oral contraceptive pill in a high-risk population. Obstet Gynecol 2006, 108:378.
12. Raine T.R., Foster-Rosales A., Upadhyay U.D., et al. One-year contraceptive continuation and pregnancy in adolescent girls and women initiating hormonal contraceptives. Obstet Gynecol 2011, 117(2 Pt 1):363.
13. Patrick D.L., Edwards T.C., Topolski T.D. Adolescent quality of life, part II: Initial validation of a new instrument. J Adolesc 2002, 25:287.
14. Terry P.C., Lane A.M., Lane H.J., et al. Development and validation of a mood measure for adolescents. J Sports Sci 1999, 17:861.
15. Nyenhuis D.L., Yamamoto C., Luchetta T., et al. Adult and geriatric normative data and validation of the profile of mood states. J Clin.Psychol 1999, 55:79.
16. Abplanalp J.M., Donnelly A.F., Rose R.M. Psychoendocrinology of the menstrual cycle: I. Enjoyment of daily activities and moods. Psychosom Med 1979, 41:587.
17. Cockerill I.M., Nevill A.M., Byrne N.C. Mood, mileage and the menstrual cycle. Br J Sports Med 1992, 26:145.
18. Hohlagschwandtner M., Husslein P., Klier C., et al. Correlation between serum testosterone levels and peripartal mood states. Acta Obstet Gynecol Scand 2001, 80:326.
19. Kanarek R.B., Ryu M., Przypek J. Preferences for foods with varying levels of salt and fat differ as a function of dietary restraint and exercise but not menstrual cycle. Physiol Behav 1995, 57:821.
20. Smith R., Cubis J., Brinsmead M., et al. Mood changes, obstetric experience and alterations in plasma cortisol, beta-endorphin and corticotrophin releasing hormone during pregnancy and the puerperium. J Psychosom Res 1990, 34:53.
21. Williams T.J., Krahenbuhl G.S. Menstrual cycle phase and running economy. Med Sci Sports Exerc 1997, 29:1609.
22. Terry PC, Lane AM: User Guide for the Brunel Mood Scale (BRUMS). 2003.
23. Lopez L.M., Grimes D.A., Gallo M.F., et al. Skin patch and vaginal ring versus combined oral contraceptives for contraception. Cochrane Database Syst Rev 2010, 3. CD003552.
24. Creinin M.D., Meyn L.A., Borgatta L., et al. Multicenter comparison of the contraceptive ring and patch: a randomized controlled trial. Obstet Gynecol 2008, 111(2 Pt 1):267.
25. Thurman A.R., Hammond N., Brown H.E., et al. Preventing repeat teen pregnancy: postpartum depot medroxyprogesterone acetate, oral contraceptive pills, or the patch?. J Pediatr Adolesc Gynecol 2007, 20:61.
26. Sucato G.S., Bhatt S.K., Murray P.J., et al. Transdermal contraception as a model for adolescent use of new methods. J Adolesc Health 2011, in press.
27. LaGuardia K.D. Performance of contraceptive patch compared with oral contraceptive pill in a high-risk population. Obstet Gynecol 2006, 108:1553.
28. Logsdon S., Richards J., Omar H.A. Long-term evaluation of the use of the transdermal contraceptive patch in adolescents. Sci World J 2004, 4:512.
29. Berenson A.B., Wiemann C.M., Rickert V.I., et al. Contraceptive outcomes among adolescents prescribed Norplant implants versus oral contraceptives after one year of use. Am J Obstet Gynecol 1997, 176:586.
30. Chacko M.R., Kozinetz C.A., Smith P.B. Assessment of oral contraceptive pill continuation in young women. J Pediatr Adolesc Gynecol 1999, 12:143.
31. Templeman C.L., Cook V., Goldsmith L.J., et al. Postpartum contraceptive use among adolescent mothers. Obstet Gynecol 2000, 95:770.
32. Woods E.R., Grace E., Havens K.K., et al. Contraceptive compliance with a levonorgestrel triphasic and a norethindrone monophasic oral contraceptive in adolescent patients. Am J Obstet Gynecol 1992, 166:901.
33. Zibners A., Cromer B.A., Hayes J. Comparison of continuation rates for hormonal contraception among adolescents. J Pediatr Adolesc Gynecol 1999, 12:90.
34. Lim S.W., Rieder J., Coupey S.M., et al. Depot medroxyprogesterone acetate use in inner-city, minority adolescents: continuation rates and characteristics of long-term users. Arch Pediatr Adolesc Med 1999, 153:1068.
35. Polaneczky M., Liblanc M. Long-term depot medroxyprogesterone acetate (Depo-Provera) use in inner-city adolescents. J Adolesc Health 1998, 23:81.
36. Gilliam M.L., Neustadt A., Kozloski M., et al. Adherence and acceptability of the contraceptive ring compared with the pill among students: a randomized controlled trial. Obstet Gynecol 2010, 115:503.
37. Godfrey E.M., Memmel L.M., Neustadt A., et al. Intrauterine contraception for adolescents aged 14-18 years: a multicenter randomized pilot study of levonorgestrel-releasing intrauterine system compared to the Copper T 380A. Contraception 2010, 81:123.
38. Paterson H., Ashton J., Harrison-Woolrych M. A nationwide cohort study of the use of the levonorgestrel intrauterine device in New Zealand adolescents. Contraception 2009, 79:433.
39. Pillai M., O'Brien K., Hill E. The levonorgestrel intrauterine system (Mirena) for the treatment of menstrual problems in adolescents with medical disorders, or physical or learning disabilities. BJOG 2010, 117:216.
40. Toma A., Jamieson M.A. Revisiting the intrauterine contraceptive device in adolescents. J Pediatr Adolesc Gynecol 2006, 19:291.
41. Pierson R.A., Archer D.F., Moreau M., et al. Ortho Evra/Evra versus oral contraceptives: follicular development and ovulation in normal cycles and after an intentional dosing error. Fertil Steril 2003, 80:34.
42. Stewart F.H., Kaunitz A.M., Laguardia K.D., et al. Extended use of transdermal norelgestromin/ethinyl estradiol: a randomized trial. Obstet Gynecol 2005, 105:1389.
43. Ott M.A., Shew M.L., Ofner S., et al. The influence of hormonal contraception on mood and sexual interest among adolescents. Arch Sex Behav 2008, 37:605.
44. Moos R.H. The development of a menstrual distress questionnaire. Psychosom Med 1968, 30:853.
45. Raine T.R., Epstein L.B., Harper C.C., et al. Attitudes toward the vaginal ring and transdermal patch among adolescents and young women. J Adolesc Health 2009, 45:262.